精东传媒

April 27, 2020

Medical scientists awarded $1.2 million for heart disease research

NSW Health’s Cardiovascular Research Capacity Program aims to improve outcomes for patients

精东传媒 of 精东传媒 researchers have been awarded $1.2 million in funding under a New South Wales Government cardiovascular disease research grants scheme.

NSW Health鈥檚  funds high quality cardiovascular research in NSW in order to drive scientific discoveries, support the development of novel and innovative therapies, and improve health outcomes for patients with cardiovascular disease.

It also provides support for clinical trials and to leverage existing research already underway across institutes, hospital and universities.

In total, NSW Health announced more than $20 million in grants for research being undertaken across a range of settings including preventive health, gene therapy, clinical services and emergency medicine.

Distinguished Professor David Adams, CEO and Executive Director of the Illawarra Health and Medical Research Institute (IHMRI), was awarded a Cardiovascular Senior Researcher Grant.

Dr Monique Francois (pictured above) from UOW鈥檚 School of Medicine and IHMRI received an Early-Mid Career Researcher Grant.

Professor Adams鈥� grant is for $750,000 over three years for his project 鈥淩ole of the intrinsic cardiac nervous system in myocardial ischaemia (decreased blood flow and oxygen to the heart muscle) and arrhythmias鈥�.

The grant will allow him to train the next generation of cardiovascular researchers in the field of studying the heart鈥檚 intrinsic nervous system.

Professor Adams has been a member of the NSW Government鈥檚 Advisory Committee for cardiovascular research since 2018. He said this success highlights the strength of cardiovascular research in the Illawarra.

鈥淚t is important to recognise that competitive cardiovascular research is going on not only in Sydney but also regional NSW.鈥�

^{Distinguished Professor David Adams.}

Dr Francois was awarded $450,000 over three years for her project 鈥淟ifestyle treatment of cardiovascular disease in patients with type 2 diabetes鈥�, which will investigate whether lifestyle therapies, such as physical activity and diet, can reduce high glucose levels after meals.

鈥淲e will look at patients with Type 2 Diabetes, and determine their effectiveness to lower postprandial hyperglycaemia and improve vascular function,鈥� she said.

Dr Francois will use the funding to hire a clinical trials coordinator, to aid collaboration with researchers, clinicians, dietitians, and accredited exercise physiologists across Australia.